Covering a wide range of intellectual property mandates, McCann FitzGerald LLP‘s IP practice regularly advises on trade mark protection, patents, trade secrets and the exploitation of IP rights. The group has expertise assisting domestic and international clients across the life sciences sector, as well as in the creative industries, consumer goods and retail spaces. With expert multi-jurisdictional patent/SPC litigation capabilities, Fiona O’Beirne leads the contentious team. Adam Finlay is at the helm of the non-contentious IP offering, specialising in trade marks. Another key contact is Shane O’Brien, particularly for patent disputes in the pharmaceutical sector.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- ‘Good technical knowledge of EU design rights.’
- ‘Shane O'Brien was excellent, in terms of service and the support that I needed in the EU.’
Key clients
- BMS
- Biogen
- Pfizer
- Health Research Board
- Research Ireland
- Alkermes
- Irish Music Rights Organisation
- Tate Europe
Work highlights
Acting for Bristol-Myers Squibb Holdings Ireland Unlimited Company in the defence of a Commercial Court patent/SPC revocation action brought by Norton (Waterford) Limited t/a Teva Pharmaceuticals Ireland (Teva) and related infringement proceedings.
Representing Pfizer in two separate patent proceedings concerning Pfizer’s Comirnaty Covid-19 vaccine.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Fiona O’Beirne; Adam Finlay
Other key lawyers
Shane O'Brien